Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wiesner

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2017
SF3B1 and BAP1 mutations in blue nevus-like melanomaKlaus G Griewank, Hansgeorg Müller, Louise A Jackett, et al.
Cancer Discovery|October 10, 2022
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive CancersLukas Leiendecker, Tobias Neumann, Pauline S Jung, et al.
Nature Communications|January 22, 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomasThomas Wiesner, Jie He, Roman Yelensky, et al.
Oncotarget|October 7, 2015
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathwayRajmohan Murali, Raghu Chandramohan, Inga Möller, et al.
Nature Genetics|August 30, 2011
Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner, Anna C Obenauf, Rajmohan Murali, et al.
Nature Cancer|February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anais Elewaut, Camille L Gerard, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Nature Genetics|June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2017
SF3B1 and BAP1 mutations in blue nevus-like melanomaKlaus G Griewank, Hansgeorg Müller, Louise A Jackett, et al.
Cancer Discovery|October 10, 2022
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive CancersLukas Leiendecker, Tobias Neumann, Pauline S Jung, et al.
Nature Communications|January 22, 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomasThomas Wiesner, Jie He, Roman Yelensky, et al.
Oncotarget|October 7, 2015
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathwayRajmohan Murali, Raghu Chandramohan, Inga Möller, et al.
Nature Genetics|August 30, 2011
Germline mutations in BAP1 predispose to melanocytic tumorsThomas Wiesner, Anna C Obenauf, Rajmohan Murali, et al.
Nature Cancer|February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anais Elewaut, Camille L Gerard, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Nature Genetics|June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Pageof 8